Activation and Induction of Cytosolic Phospholipase A2 by TNF-α Mediated Through Nox2, MAPKs, NF-κB, and p300 in Human Tracheal Smooth Muscle Cells

Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-alpha (TNF-alpha). However, the mechanisms underlying TNF-alpha-induced cPLA(2) expression and PGE(2) synthesis in human tracheal smooth muscle cells (HTSMCs) remain unknown. Here, we report that TNF-alpha-induced cPLA(2) protein and mRNA expression, PGE(2) production, and phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, which were attenuated by pretreatment with a ROS scavenger [N-acetyl-L-cysteine, (NAC)] and the inhibitors of NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], MEK1/2 (U0126), p38 MAPK (SB202190), and JNK1/2 (SP600125) or transfection with siRNA of Nox2, p47(phox), MEK1, p42, p38, or JNK2. TNF-alpha-induced cPLA(2) expression was also inhibited by pretreatment with a selective NF-kappa B inhibitor [helenalin (HLN)] or transfection with dominant negative mutants of NF-kappa B inducing kinase (NIK) or IkB kinase (IKK)alpha/beta. TNF-alpha-induced NF-kappa B translocation was blocked by pretreatment with NAC, DPI, APO, or HLN, but not by U0126, SB202190, or SP600125. In addition, pretreatment with curcumin (a p300 inhibitor) or transfection with p300 siRNA blocked cPLA(2) expression and PGE(2) synthesis induced by TNF-alpha. We further confirmed that p300 was associated with the cPLA(2) promoter which was dynamically linked to histone H4 acetylation stimulated by TNF-alpha, determined by chromatin immunoprecipitation assay. Association of p300 and histone H4 to cPLA(2) promoter was inhibited by U0126, SB202190, and SP600125. These results suggested that in HTSMCs, activation of p47(phox), MAPKs, NF-kappa B, and p300 is essential for TNF-alpha-induced cPLA(2) expression and PGE(2) release. J. Cell. Physiol. 226: 2103-2114, 2011. (C) 2010 Wiley-Liss, Inc.